Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

226 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Oral vinorelbine in the treatment of non-small-cell lung cancer.
Barletta G, Genova C, Rijavec E, Burrafato G, Biello F, Sini C, Dal Bello MG, Coco S, Truini A, Vanni I, Alama A, Beltramini S, Grassi MA, Boccardo F, Grossi F. Barletta G, et al. Among authors: truini a. Expert Opin Pharmacother. 2014 Aug;15(11):1585-99. doi: 10.1517/14656566.2014.934224. Epub 2014 Jun 27. Expert Opin Pharmacother. 2014. PMID: 24972635 Review.
Sequential use of vinorelbine followed by gefitinib enhances the antitumor effect in NSCLC cell lines poorly responsive to reversible EGFR tyrosine kinase inhibitors.
Dal Bello MG, Alama A, Barletta G, Coco S, Truini A, Vanni I, Boccardo S, Genova C, Rijavec E, Biello F, Bottoni G, Sambuceti G, Grossi F. Dal Bello MG, et al. Among authors: truini a. Int J Cancer. 2015 Dec 15;137(12):2947-58. doi: 10.1002/ijc.29647. Epub 2015 Jul 15. Int J Cancer. 2015. PMID: 26089022
Belagenpumatucel-L for the treatment of non-small cell lung cancer.
Rijavec E, Biello F, Genova C, Barletta G, Maggioni C, Dal Bello MG, Coco S, Truini A, Vanni I, Alama A, Beltramini S, Grassi MA, Boccardo F, Grossi F. Rijavec E, et al. Among authors: truini a. Expert Opin Biol Ther. 2015;15(9):1371-9. doi: 10.1517/14712598.2015.1073709. Epub 2015 Jul 27. Expert Opin Biol Ther. 2015. PMID: 26211534 Review.
Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy.
Coco S, Alama A, Vanni I, Fontana V, Genova C, Dal Bello MG, Truini A, Rijavec E, Biello F, Sini C, Burrafato G, Maggioni C, Barletta G, Grossi F. Coco S, et al. Among authors: truini a. Int J Mol Sci. 2017 May 11;18(5):1035. doi: 10.3390/ijms18051035. Int J Mol Sci. 2017. PMID: 28492516 Free PMC article.
Pemetrexed for the treatment of non-small cell lung cancer.
Genova C, Rijavec E, Truini A, Coco S, Sini C, Barletta G, Dal Bello MG, Alama A, Savarino G, Pronzato P, Boccardo F, Grossi F. Genova C, et al. Among authors: truini a. Expert Opin Pharmacother. 2013 Aug;14(11):1545-58. doi: 10.1517/14656566.2013.802774. Epub 2013 May 17. Expert Opin Pharmacother. 2013. PMID: 23683110 Review.
Afatinib for the treatment of advanced non-small-cell lung cancer.
Genova C, Rijavec E, Barletta G, Burrafato G, Biello F, Dal Bello MG, Coco S, Truini A, Alama A, Boccardo F, Grossi F. Genova C, et al. Among authors: truini a. Expert Opin Pharmacother. 2014 Apr;15(6):889-903. doi: 10.1517/14656566.2014.902445. Expert Opin Pharmacother. 2014. PMID: 24646054 Review.
226 results